PT1122262E - Péptidos específicos de zonas neovasculares - Google Patents
Péptidos específicos de zonas neovasculares Download PDFInfo
- Publication number
- PT1122262E PT1122262E PT99947941T PT99947941T PT1122262E PT 1122262 E PT1122262 E PT 1122262E PT 99947941 T PT99947941 T PT 99947941T PT 99947941 T PT99947941 T PT 99947941T PT 1122262 E PT1122262 E PT 1122262E
- Authority
- PT
- Portugal
- Prior art keywords
- cancer
- peptides
- neovascular
- specific peptides
- tissues
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 4
- 201000011510 cancer Diseases 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 239000000412 dendrimer Substances 0.000 abstract 1
- 229920000736 dendritic polymer Polymers 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29519898 | 1998-10-16 | ||
| JP19470699 | 1999-07-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1122262E true PT1122262E (pt) | 2010-01-27 |
Family
ID=26508673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99947941T PT1122262E (pt) | 1998-10-16 | 1999-10-15 | Péptidos específicos de zonas neovasculares |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6753310B1 (pt) |
| EP (2) | EP1783140A3 (pt) |
| JP (1) | JP4439120B2 (pt) |
| AT (1) | ATE453667T1 (pt) |
| CA (2) | CA2347136A1 (pt) |
| CY (1) | CY1109881T1 (pt) |
| DE (1) | DE69941877D1 (pt) |
| DK (1) | DK1122262T3 (pt) |
| ES (1) | ES2337321T3 (pt) |
| PT (1) | PT1122262E (pt) |
| WO (1) | WO2000023476A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1263776A2 (en) * | 2000-03-16 | 2002-12-11 | University Of Pittsburgh | Peptides targeting specifically tumor-derived endothelial cells |
| US6906036B2 (en) * | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US7186693B2 (en) * | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
| US7071164B2 (en) * | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
| TR200500108T2 (tr) * | 2002-07-18 | 2005-04-21 | Helix Biopharma Corp. | Kanser Hücresi Gelişiminin İnhibe Edilmesinde Üreaz Kullanımı |
| US7148194B2 (en) * | 2002-12-30 | 2006-12-12 | Kimberly-Clark Worldwide, Inc. | Method to increase fibronectin |
| US7189700B2 (en) * | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
| US8440217B1 (en) | 2005-06-15 | 2013-05-14 | Mawaheb M. EL-Naggar | Method and system with contact lens product for treating and preventing adverse eye conditions |
| JP5250229B2 (ja) * | 2007-09-25 | 2013-07-31 | 独立行政法人科学技術振興機構 | カーボンナノホーン |
| WO2009048870A1 (en) * | 2007-10-08 | 2009-04-16 | Baylor College Of Medicine | Peptide dendrimers: affinity reagents for binding noroviruses |
| WO2009103127A1 (en) * | 2008-02-22 | 2009-08-27 | Inter-K Pty Limited | Therapeutic peptides |
| MX2012005859A (es) * | 2009-11-23 | 2012-12-17 | Palatin Technologies Inc | Peptidos lineales especificos del receptor de melanocortina-1. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622852A (en) * | 1994-10-31 | 1997-04-22 | Washington University | Bcl-x/Bcl-2 associated cell death regulator |
| JP4173544B2 (ja) * | 1995-11-16 | 2008-10-29 | ノバルティス アクチエンゲゼルシャフト | 治療剤としての、または診断におけるｒａｃ−プロテインキナーゼ |
| US5922676A (en) | 1996-09-20 | 1999-07-13 | The Burnham Institute | Methods of inhibiting cancer by using superfibronectin |
| CH692507A5 (de) * | 1997-04-26 | 2002-07-15 | Peter Prof Dr Sonderegger | Neurotrypsin als aktive Verbindung in einem Medikament. |
| AU1633999A (en) | 1997-12-09 | 1999-06-28 | Children's Medical Center Corporation | Soluble inhibitors of vascular endothelial growth factor and use thereof |
| JPH11243964A (ja) * | 1998-03-03 | 1999-09-14 | Natl Food Res Inst | イネオルニチンカルバミルトランスフェラーゼ遺伝子、該遺伝子を含むベクター及び形質転換体 |
| EP0950709A1 (en) * | 1998-04-17 | 1999-10-20 | Hoechst Marion Roussel Deutschland GmbH | Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression |
| CN1158386C (zh) * | 1998-04-29 | 2004-07-21 | 吉尼西斯研究及发展有限公司 | 从皮肤细胞中分离的多核苷酸及其使用方法 |
| WO1999061476A1 (en) * | 1998-05-22 | 1999-12-02 | Abbott Laboratories | Peptide antiangiogenic drugs |
-
1999
- 1999-10-15 CA CA002347136A patent/CA2347136A1/en not_active Abandoned
- 1999-10-15 ES ES99947941T patent/ES2337321T3/es not_active Expired - Lifetime
- 1999-10-15 PT PT99947941T patent/PT1122262E/pt unknown
- 1999-10-15 US US09/807,278 patent/US6753310B1/en not_active Expired - Fee Related
- 1999-10-15 AT AT99947941T patent/ATE453667T1/de active
- 1999-10-15 EP EP06021030A patent/EP1783140A3/en not_active Withdrawn
- 1999-10-15 JP JP2000577201A patent/JP4439120B2/ja not_active Expired - Fee Related
- 1999-10-15 EP EP99947941A patent/EP1122262B1/en not_active Expired - Lifetime
- 1999-10-15 DK DK99947941.3T patent/DK1122262T3/da active
- 1999-10-15 DE DE69941877T patent/DE69941877D1/de not_active Expired - Lifetime
- 1999-10-15 CA CA002622786A patent/CA2622786A1/en not_active Abandoned
- 1999-10-15 WO PCT/JP1999/005730 patent/WO2000023476A1/ja active Application Filing
-
2010
- 2010-02-25 CY CY20101100192T patent/CY1109881T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE453667T1 (de) | 2010-01-15 |
| DK1122262T3 (da) | 2010-04-19 |
| CA2347136A1 (en) | 2000-04-27 |
| EP1783140A3 (en) | 2007-07-11 |
| DE69941877D1 (de) | 2010-02-11 |
| ES2337321T3 (es) | 2010-04-22 |
| EP1783140A2 (en) | 2007-05-09 |
| US6753310B1 (en) | 2004-06-22 |
| CA2622786A1 (en) | 2000-04-27 |
| EP1122262A1 (en) | 2001-08-08 |
| WO2000023476A1 (fr) | 2000-04-27 |
| JP4439120B2 (ja) | 2010-03-24 |
| CY1109881T1 (el) | 2014-09-10 |
| EP1122262B1 (en) | 2009-12-30 |
| EP1122262A4 (en) | 2003-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109881T1 (el) | Νεοαγγειακα-συγκεκριμενα πεπτιδια | |
| AU4778101A (en) | Novel polypeptides, and nucleic acids encoding the same | |
| NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
| MY119276A (en) | Pharmaceutical composition for immunomodulation based on peptides and adjuvants | |
| IL131381A0 (en) | Therapeutic agent for lymphatic tumors | |
| AU2861595A (en) | Stimulation of hair growth by peptide-copper complexes | |
| WO2003045309A3 (en) | Peptides, peptide compositions,and methods of use in binding p 185 | |
| GB0106315D0 (en) | Transfection complexes | |
| WO2001085777A3 (en) | Therapeutic pore-forming peptides | |
| EP1536006A4 (en) | CANCER-ANIMALS AND THEIR USE | |
| EP1008351A4 (en) | CANCEROSTATIC AGENTS | |
| WO2002058589A3 (en) | Agents and methods for promoting bone growth | |
| IL142292A0 (en) | Ion exchange tumor targeting | |
| IL129368A0 (en) | Immunogenic TLP composition | |
| WO2001000784A3 (fr) | COMPOSE PEPTIDIQUE DERIVE D'UNE ORF DECALEE DU GENE iCE | |
| TW200517125A (en) | Pharmaceutical composition for treatment of solid cancers | |
| WO2002100897A3 (fr) | Complexes moleculaires brca1/acc alpha, applications diagnostiques et therapeutiques | |
| WO2001098363A3 (en) | Peptides for use in the immunotherapy of renal cell carcinoma |